ArchivesMagazine - 21 Aug 2014Enhance your portfolio returns Focus on the pharmaceutical plays with the best pricing power 21 August 2014|Feature|by Mark Dunne Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < Continental contenders Win-Win > Issue: 21 Aug 2014 - Page 54 | Contents Next: Win-Win Previous: Continental contenders Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Mark Dunne Issue Contents Chartist Using charts for currency trades Chartist: US dollar/Canadian dollar Chartist: British pound/US dollar Feature The pricing conundrum Preview: Grafton Preview: Capital Drilling Preview: Foxtons Win-Win Grab Next opportunity Small Caps Best & Worst Performers table TLA seeks home run Back to school cribsheet A question of choice Growth on the agenda Discount battle to intensify Get in the fast lane: Industrials Manager makes energetic case Enhance your portfolio returns Emerging winners Loonie to get last laugh Sidestep sterling surge The Best & Worst Performers: FTSE 350, Global Markets, Commodities, Forex, Sovereign Yields Fight For Your Rights U-turn on voting charge Taking action on Lloyds deal Forum Pick of the broker pack Funds Continental contenders News Grab retailers for a rebound News in brief: CLS, Innovation, EMED Mining, IXICO, Braemar Shipping Services and Finsbury Food’s Rotate out of Regus Dig into BHP Uranium price recovery Cut Daisy now Plays Kingspan’s US boost Well-Kalibrated trade Plays update: Sprue Aegis Plays update: Henry Boot Plays update: Ashcourt Rowan Under The Bonnet Best back off from Balfour
